[SaNOtize in South China Morning Post] Li Ka-shing’s Horizons Ventures makes undisclosed investment in Canadian Covid-19 treatment start-up SaNOtize

• Horizons and Jerusalem-based OurCrowd lead US$24 million Series B funding round
• Funding will go towards the expansion of a third-phase clinical trial of a nasal spray aimed at treating and preventing Covid-19

Read more here.